Burke Steven Keith (CIK 1619834) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-22). Recent activity: Buy SCYX (5,750 shares), Sell AKBA (21,582 shares), Sell AKBA (25,375 shares), Sell AKBA (20,701 shares), Buy AKBA (204,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-22 | SCYNEXIS INC (SCYX) | Director | Buy | 5,750 | $0 |
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | Sell | 21,582 | $29,999 |
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | Sell | 25,375 | $35,271 |
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | Sell | 20,701 | $28,774 |
| 2026-02-03 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | Buy | 204,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-22